Global Genetic Testing For Neurological Disorders Market Growth (Status and Outlook) 2026-2032
The global Genetic Testing For Neurological Disorders market size is predicted to grow from US$ 3059 million in 2025 to US$ 6146 million in 2032; it is expected to grow at a CAGR of 10.7% from 2026 to 2032.
Genetic testing for neurological diseases uses technologies such as gene sequencing to analyze pathogenic variants related to the nervous system in the patient's DNA. It is used to confirm the molecular causes of diseases such as hereditary epilepsy, leukodystrophy, motor neuron disease, and assist in clinical diagnosis, prognosis assessment, and family genetic counseling.
United States market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Genetic Testing For Neurological Disorders players cover Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Genetic Testing For Neurological Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Testing For Neurological Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Testing For Neurological Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Testing For Neurological Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Testing For Neurological Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Testing For Neurological Disorders market by product type, application, key players and key regions and countries.
Genetic testing for neurological diseases uses technologies such as gene sequencing to analyze pathogenic variants related to the nervous system in the patient's DNA. It is used to confirm the molecular causes of diseases such as hereditary epilepsy, leukodystrophy, motor neuron disease, and assist in clinical diagnosis, prognosis assessment, and family genetic counseling.
United States market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Genetic Testing For Neurological Disorders is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Genetic Testing For Neurological Disorders players cover Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LPI (LP Information)' newest research report, the “Genetic Testing For Neurological Disorders Industry Forecast” looks at past sales and reviews total world Genetic Testing For Neurological Disorders sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetic Testing For Neurological Disorders sales for 2026 through 2032. With Genetic Testing For Neurological Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Testing For Neurological Disorders industry.This Insight Report provides a comprehensive analysis of the global Genetic Testing For Neurological Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Testing For Neurological Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Testing For Neurological Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Testing For Neurological Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Testing For Neurological Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Testing For Neurological Disorders market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Exome Sequencing
- Whole Genome Sequencing
- RNA Sequencing
- General DNA Testing
Segmentation by Application:
- Hospitals
- Specialty Clinics
- Diagnostics Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- CENTOGENE
- Victorian Clinical Genetics Services
- PacBio
- Mayo Clinic
- Quest Diagnostics
- MedGenome Labs
- GeneDx
- Connecticut Children's
- Labcorp (Invitae/MNG Laboratories)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Testing For Neurological Disorders Market Size (2021-2032)
2.1.2 Genetic Testing For Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Testing For Neurological Disorders by Country/Region (2021, 2025 & 2032)
2.2 Genetic Testing For Neurological Disorders Segment by Type
2.2.1 Exome Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 RNA Sequencing
2.2.4 General DNA Testing
2.2.5 Genetic Testing For Neurological Disorders Market Size by Type
2.2.5.1 Genetic Testing For Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
2.3 Genetic Testing For Neurological Disorders Segment by Application
2.3.1 Hospitals
2.3.2 Specialty Clinics
2.3.3 Diagnostics Laboratories
2.3.4 Genetic Testing For Neurological Disorders Market Size by Application
2.3.4.1 Genetic Testing For Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
3 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SIZE BY PLAYER
3.1 Genetic Testing For Neurological Disorders Market Size Market Share by Player
3.1.1 Global Genetic Testing For Neurological Disorders Revenue by Player (2021-2026)
3.1.2 Global Genetic Testing For Neurological Disorders Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Testing For Neurological Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR NEUROLOGICAL DISORDERS BY REGION
4.1 Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
4.2 Global Genetic Testing For Neurological Disorders Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.4 APAC Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.5 Europe Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
5.2 Americas Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
5.3 Americas Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
6.2 APAC Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
6.3 APAC Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
7.2 Europe Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
7.3 Europe Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Testing For Neurological Disorders by Region (2021-2026)
8.2 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET FORECAST
10.1 Global Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.1.1 Global Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.1.2 Americas Genetic Testing For Neurological Disorders Forecast
10.1.3 APAC Genetic Testing For Neurological Disorders Forecast
10.1.4 Europe Genetic Testing For Neurological Disorders Forecast
10.1.5 Middle East & Africa Genetic Testing For Neurological Disorders Forecast
10.2 Americas Genetic Testing For Neurological Disorders Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Testing For Neurological Disorders Forecast
10.2.2 Canada Market Genetic Testing For Neurological Disorders Forecast
10.2.3 Mexico Market Genetic Testing For Neurological Disorders Forecast
10.2.4 Brazil Market Genetic Testing For Neurological Disorders Forecast
10.3 APAC Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.3.1 China Genetic Testing For Neurological Disorders Market Forecast
10.3.2 Japan Market Genetic Testing For Neurological Disorders Forecast
10.3.3 Korea Market Genetic Testing For Neurological Disorders Forecast
10.3.4 Southeast Asia Market Genetic Testing For Neurological Disorders Forecast
10.3.5 India Market Genetic Testing For Neurological Disorders Forecast
10.3.6 Australia Market Genetic Testing For Neurological Disorders Forecast
10.4 Europe Genetic Testing For Neurological Disorders Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Testing For Neurological Disorders Forecast
10.4.2 France Market Genetic Testing For Neurological Disorders Forecast
10.4.3 UK Market Genetic Testing For Neurological Disorders Forecast
10.4.4 Italy Market Genetic Testing For Neurological Disorders Forecast
10.4.5 Russia Market Genetic Testing For Neurological Disorders Forecast
10.5 Middle East & Africa Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Testing For Neurological Disorders Forecast
10.5.2 South Africa Market Genetic Testing For Neurological Disorders Forecast
10.5.3 Israel Market Genetic Testing For Neurological Disorders Forecast
10.5.4 Turkey Market Genetic Testing For Neurological Disorders Forecast
10.6 Global Genetic Testing For Neurological Disorders Forecast by Type (2027-2032)
10.7 Global Genetic Testing For Neurological Disorders Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Testing For Neurological Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Genetic Testing For Neurological Disorders Product Offered
11.1.3 Illumina Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 CENTOGENE
11.2.1 CENTOGENE Company Information
11.2.2 CENTOGENE Genetic Testing For Neurological Disorders Product Offered
11.2.3 CENTOGENE Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 CENTOGENE Main Business Overview
11.2.5 CENTOGENE Latest Developments
11.3 Victorian Clinical Genetics Services
11.3.1 Victorian Clinical Genetics Services Company Information
11.3.2 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Offered
11.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Victorian Clinical Genetics Services Main Business Overview
11.3.5 Victorian Clinical Genetics Services Latest Developments
11.4 PacBio
11.4.1 PacBio Company Information
11.4.2 PacBio Genetic Testing For Neurological Disorders Product Offered
11.4.3 PacBio Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 PacBio Main Business Overview
11.4.5 PacBio Latest Developments
11.5 Mayo Clinic
11.5.1 Mayo Clinic Company Information
11.5.2 Mayo Clinic Genetic Testing For Neurological Disorders Product Offered
11.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Main Business Overview
11.5.5 Mayo Clinic Latest Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Information
11.6.2 Quest Diagnostics Genetic Testing For Neurological Disorders Product Offered
11.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Quest Diagnostics Main Business Overview
11.6.5 Quest Diagnostics Latest Developments
11.7 MedGenome Labs
11.7.1 MedGenome Labs Company Information
11.7.2 MedGenome Labs Genetic Testing For Neurological Disorders Product Offered
11.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 MedGenome Labs Main Business Overview
11.7.5 MedGenome Labs Latest Developments
11.8 GeneDx
11.8.1 GeneDx Company Information
11.8.2 GeneDx Genetic Testing For Neurological Disorders Product Offered
11.8.3 GeneDx Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GeneDx Main Business Overview
11.8.5 GeneDx Latest Developments
11.9 Connecticut Children's
11.9.1 Connecticut Children's Company Information
11.9.2 Connecticut Children's Genetic Testing For Neurological Disorders Product Offered
11.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Connecticut Children's Main Business Overview
11.9.5 Connecticut Children's Latest Developments
11.10 Labcorp (Invitae/MNG Laboratories)
11.10.1 Labcorp (Invitae/MNG Laboratories) Company Information
11.10.2 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Offered
11.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Labcorp (Invitae/MNG Laboratories) Main Business Overview
11.10.5 Labcorp (Invitae/MNG Laboratories) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Testing For Neurological Disorders Market Size (2021-2032)
2.1.2 Genetic Testing For Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Testing For Neurological Disorders by Country/Region (2021, 2025 & 2032)
2.2 Genetic Testing For Neurological Disorders Segment by Type
2.2.1 Exome Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 RNA Sequencing
2.2.4 General DNA Testing
2.2.5 Genetic Testing For Neurological Disorders Market Size by Type
2.2.5.1 Genetic Testing For Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
2.3 Genetic Testing For Neurological Disorders Segment by Application
2.3.1 Hospitals
2.3.2 Specialty Clinics
2.3.3 Diagnostics Laboratories
2.3.4 Genetic Testing For Neurological Disorders Market Size by Application
2.3.4.1 Genetic Testing For Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
3 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SIZE BY PLAYER
3.1 Genetic Testing For Neurological Disorders Market Size Market Share by Player
3.1.1 Global Genetic Testing For Neurological Disorders Revenue by Player (2021-2026)
3.1.2 Global Genetic Testing For Neurological Disorders Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Testing For Neurological Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR NEUROLOGICAL DISORDERS BY REGION
4.1 Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
4.2 Global Genetic Testing For Neurological Disorders Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.4 APAC Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.5 Europe Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Testing For Neurological Disorders Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
5.2 Americas Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
5.3 Americas Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
6.2 APAC Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
6.3 APAC Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
7.2 Europe Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
7.3 Europe Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Testing For Neurological Disorders by Region (2021-2026)
8.2 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET FORECAST
10.1 Global Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.1.1 Global Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.1.2 Americas Genetic Testing For Neurological Disorders Forecast
10.1.3 APAC Genetic Testing For Neurological Disorders Forecast
10.1.4 Europe Genetic Testing For Neurological Disorders Forecast
10.1.5 Middle East & Africa Genetic Testing For Neurological Disorders Forecast
10.2 Americas Genetic Testing For Neurological Disorders Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Testing For Neurological Disorders Forecast
10.2.2 Canada Market Genetic Testing For Neurological Disorders Forecast
10.2.3 Mexico Market Genetic Testing For Neurological Disorders Forecast
10.2.4 Brazil Market Genetic Testing For Neurological Disorders Forecast
10.3 APAC Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.3.1 China Genetic Testing For Neurological Disorders Market Forecast
10.3.2 Japan Market Genetic Testing For Neurological Disorders Forecast
10.3.3 Korea Market Genetic Testing For Neurological Disorders Forecast
10.3.4 Southeast Asia Market Genetic Testing For Neurological Disorders Forecast
10.3.5 India Market Genetic Testing For Neurological Disorders Forecast
10.3.6 Australia Market Genetic Testing For Neurological Disorders Forecast
10.4 Europe Genetic Testing For Neurological Disorders Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Testing For Neurological Disorders Forecast
10.4.2 France Market Genetic Testing For Neurological Disorders Forecast
10.4.3 UK Market Genetic Testing For Neurological Disorders Forecast
10.4.4 Italy Market Genetic Testing For Neurological Disorders Forecast
10.4.5 Russia Market Genetic Testing For Neurological Disorders Forecast
10.5 Middle East & Africa Genetic Testing For Neurological Disorders Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Testing For Neurological Disorders Forecast
10.5.2 South Africa Market Genetic Testing For Neurological Disorders Forecast
10.5.3 Israel Market Genetic Testing For Neurological Disorders Forecast
10.5.4 Turkey Market Genetic Testing For Neurological Disorders Forecast
10.6 Global Genetic Testing For Neurological Disorders Forecast by Type (2027-2032)
10.7 Global Genetic Testing For Neurological Disorders Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Testing For Neurological Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Genetic Testing For Neurological Disorders Product Offered
11.1.3 Illumina Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 CENTOGENE
11.2.1 CENTOGENE Company Information
11.2.2 CENTOGENE Genetic Testing For Neurological Disorders Product Offered
11.2.3 CENTOGENE Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 CENTOGENE Main Business Overview
11.2.5 CENTOGENE Latest Developments
11.3 Victorian Clinical Genetics Services
11.3.1 Victorian Clinical Genetics Services Company Information
11.3.2 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Offered
11.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Victorian Clinical Genetics Services Main Business Overview
11.3.5 Victorian Clinical Genetics Services Latest Developments
11.4 PacBio
11.4.1 PacBio Company Information
11.4.2 PacBio Genetic Testing For Neurological Disorders Product Offered
11.4.3 PacBio Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 PacBio Main Business Overview
11.4.5 PacBio Latest Developments
11.5 Mayo Clinic
11.5.1 Mayo Clinic Company Information
11.5.2 Mayo Clinic Genetic Testing For Neurological Disorders Product Offered
11.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Main Business Overview
11.5.5 Mayo Clinic Latest Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Information
11.6.2 Quest Diagnostics Genetic Testing For Neurological Disorders Product Offered
11.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Quest Diagnostics Main Business Overview
11.6.5 Quest Diagnostics Latest Developments
11.7 MedGenome Labs
11.7.1 MedGenome Labs Company Information
11.7.2 MedGenome Labs Genetic Testing For Neurological Disorders Product Offered
11.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 MedGenome Labs Main Business Overview
11.7.5 MedGenome Labs Latest Developments
11.8 GeneDx
11.8.1 GeneDx Company Information
11.8.2 GeneDx Genetic Testing For Neurological Disorders Product Offered
11.8.3 GeneDx Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GeneDx Main Business Overview
11.8.5 GeneDx Latest Developments
11.9 Connecticut Children's
11.9.1 Connecticut Children's Company Information
11.9.2 Connecticut Children's Genetic Testing For Neurological Disorders Product Offered
11.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Connecticut Children's Main Business Overview
11.9.5 Connecticut Children's Latest Developments
11.10 Labcorp (Invitae/MNG Laboratories)
11.10.1 Labcorp (Invitae/MNG Laboratories) Company Information
11.10.2 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Offered
11.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Labcorp (Invitae/MNG Laboratories) Main Business Overview
11.10.5 Labcorp (Invitae/MNG Laboratories) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetic Testing For Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Testing For Neurological Disorders Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Exome Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. Major Players of RNA Sequencing
Table 6. Major Players of General DNA Testing
Table 7. Genetic Testing For Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 10. Genetic Testing For Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 13. Global Genetic Testing For Neurological Disorders Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Genetic Testing For Neurological Disorders Revenue Market Share by Player (2021-2026)
Table 15. Genetic Testing For Neurological Disorders Key Players Head office and Products Offered
Table 16. Genetic Testing For Neurological Disorders Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 21. Global Genetic Testing For Neurological Disorders Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Genetic Testing For Neurological Disorders Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Genetic Testing For Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 25. Americas Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 27. Americas Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 29. APAC Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 31. APAC Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 35. Europe Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Testing For Neurological Disorders
Table 41. Key Market Challenges & Risks of Genetic Testing For Neurological Disorders
Table 42. Key Industry Trends of Genetic Testing For Neurological Disorders
Table 43. Global Genetic Testing For Neurological Disorders Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Genetic Testing For Neurological Disorders Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Illumina Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 48. Illumina Genetic Testing For Neurological Disorders Product Offered
Table 49. Illumina Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Illumina Main Business
Table 51. Illumina Latest Developments
Table 52. CENTOGENE Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 53. CENTOGENE Genetic Testing For Neurological Disorders Product Offered
Table 54. CENTOGENE Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. CENTOGENE Main Business
Table 56. CENTOGENE Latest Developments
Table 57. Victorian Clinical Genetics Services Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 58. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Offered
Table 59. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Victorian Clinical Genetics Services Main Business
Table 61. Victorian Clinical Genetics Services Latest Developments
Table 62. PacBio Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 63. PacBio Genetic Testing For Neurological Disorders Product Offered
Table 64. PacBio Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PacBio Main Business
Table 66. PacBio Latest Developments
Table 67. Mayo Clinic Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 68. Mayo Clinic Genetic Testing For Neurological Disorders Product Offered
Table 69. Mayo Clinic Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mayo Clinic Main Business
Table 71. Mayo Clinic Latest Developments
Table 72. Quest Diagnostics Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 73. Quest Diagnostics Genetic Testing For Neurological Disorders Product Offered
Table 74. Quest Diagnostics Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Quest Diagnostics Main Business
Table 76. Quest Diagnostics Latest Developments
Table 77. MedGenome Labs Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 78. MedGenome Labs Genetic Testing For Neurological Disorders Product Offered
Table 79. MedGenome Labs Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. MedGenome Labs Main Business
Table 81. MedGenome Labs Latest Developments
Table 82. GeneDx Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 83. GeneDx Genetic Testing For Neurological Disorders Product Offered
Table 84. GeneDx Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. GeneDx Main Business
Table 86. GeneDx Latest Developments
Table 87. Connecticut Children's Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 88. Connecticut Children's Genetic Testing For Neurological Disorders Product Offered
Table 89. Connecticut Children's Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Connecticut Children's Main Business
Table 91. Connecticut Children's Latest Developments
Table 92. Labcorp (Invitae/MNG Laboratories) Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 93. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Offered
Table 94. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Labcorp (Invitae/MNG Laboratories) Main Business
Table 96. Labcorp (Invitae/MNG Laboratories) Latest Developments
Table 1. Genetic Testing For Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Testing For Neurological Disorders Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Exome Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. Major Players of RNA Sequencing
Table 6. Major Players of General DNA Testing
Table 7. Genetic Testing For Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 10. Genetic Testing For Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 13. Global Genetic Testing For Neurological Disorders Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Genetic Testing For Neurological Disorders Revenue Market Share by Player (2021-2026)
Table 15. Genetic Testing For Neurological Disorders Key Players Head office and Products Offered
Table 16. Genetic Testing For Neurological Disorders Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 21. Global Genetic Testing For Neurological Disorders Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Genetic Testing For Neurological Disorders Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Genetic Testing For Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 25. Americas Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 27. Americas Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 29. APAC Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 31. APAC Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 35. Europe Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Testing For Neurological Disorders
Table 41. Key Market Challenges & Risks of Genetic Testing For Neurological Disorders
Table 42. Key Industry Trends of Genetic Testing For Neurological Disorders
Table 43. Global Genetic Testing For Neurological Disorders Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Genetic Testing For Neurological Disorders Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Illumina Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 48. Illumina Genetic Testing For Neurological Disorders Product Offered
Table 49. Illumina Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Illumina Main Business
Table 51. Illumina Latest Developments
Table 52. CENTOGENE Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 53. CENTOGENE Genetic Testing For Neurological Disorders Product Offered
Table 54. CENTOGENE Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. CENTOGENE Main Business
Table 56. CENTOGENE Latest Developments
Table 57. Victorian Clinical Genetics Services Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 58. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Offered
Table 59. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Victorian Clinical Genetics Services Main Business
Table 61. Victorian Clinical Genetics Services Latest Developments
Table 62. PacBio Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 63. PacBio Genetic Testing For Neurological Disorders Product Offered
Table 64. PacBio Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PacBio Main Business
Table 66. PacBio Latest Developments
Table 67. Mayo Clinic Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 68. Mayo Clinic Genetic Testing For Neurological Disorders Product Offered
Table 69. Mayo Clinic Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mayo Clinic Main Business
Table 71. Mayo Clinic Latest Developments
Table 72. Quest Diagnostics Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 73. Quest Diagnostics Genetic Testing For Neurological Disorders Product Offered
Table 74. Quest Diagnostics Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Quest Diagnostics Main Business
Table 76. Quest Diagnostics Latest Developments
Table 77. MedGenome Labs Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 78. MedGenome Labs Genetic Testing For Neurological Disorders Product Offered
Table 79. MedGenome Labs Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. MedGenome Labs Main Business
Table 81. MedGenome Labs Latest Developments
Table 82. GeneDx Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 83. GeneDx Genetic Testing For Neurological Disorders Product Offered
Table 84. GeneDx Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. GeneDx Main Business
Table 86. GeneDx Latest Developments
Table 87. Connecticut Children's Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 88. Connecticut Children's Genetic Testing For Neurological Disorders Product Offered
Table 89. Connecticut Children's Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Connecticut Children's Main Business
Table 91. Connecticut Children's Latest Developments
Table 92. Labcorp (Invitae/MNG Laboratories) Details, Company Type, Genetic Testing For Neurological Disorders Area Served and Its Competitors
Table 93. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Offered
Table 94. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Labcorp (Invitae/MNG Laboratories) Main Business
Table 96. Labcorp (Invitae/MNG Laboratories) Latest Developments
LIST OF FIGURES
Figure 1. Genetic Testing For Neurological Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Testing For Neurological Disorders Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Testing For Neurological Disorders Sales Market Share by Country/Region (2025)
Figure 8. Genetic Testing For Neurological Disorders Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Testing For Neurological Disorders Market Size Market Share by Type in 2025
Figure 10. Genetic Testing For Neurological Disorders in Hospitals
Figure 11. Global Genetic Testing For Neurological Disorders Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Genetic Testing For Neurological Disorders in Specialty Clinics
Figure 13. Global Genetic Testing For Neurological Disorders Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 14. Genetic Testing For Neurological Disorders in Diagnostics Laboratories
Figure 15. Global Genetic Testing For Neurological Disorders Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 16. Global Genetic Testing For Neurological Disorders Market Size Market Share by Application in 2025
Figure 17. Global Genetic Testing For Neurological Disorders Revenue Market Share by Player in 2025
Figure 18. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 19. Americas Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 20. APAC Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 21. Europe Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 23. Americas Genetic Testing For Neurological Disorders Value Market Share by Country in 2025
Figure 24. United States Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2025
Figure 29. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 30. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 31. China Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 35. India Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2025
Figure 38. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 39. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 40. Germany Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 41. France Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 54. APAC Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 55. Europe Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 57. United States Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 58. Canada Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 59. Mexico Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 60. Brazil Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 61. China Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 62. Japan Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 63. Korea Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 65. India Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 66. Australia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 67. Germany Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 68. France Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 69. UK Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 70. Italy Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 71. Russia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 72. Egypt Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 73. South Africa Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 74. Israel Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 75. Turkey Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 76. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 1. Genetic Testing For Neurological Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Testing For Neurological Disorders Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Testing For Neurological Disorders Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Testing For Neurological Disorders Sales Market Share by Country/Region (2025)
Figure 8. Genetic Testing For Neurological Disorders Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Testing For Neurological Disorders Market Size Market Share by Type in 2025
Figure 10. Genetic Testing For Neurological Disorders in Hospitals
Figure 11. Global Genetic Testing For Neurological Disorders Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Genetic Testing For Neurological Disorders in Specialty Clinics
Figure 13. Global Genetic Testing For Neurological Disorders Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 14. Genetic Testing For Neurological Disorders in Diagnostics Laboratories
Figure 15. Global Genetic Testing For Neurological Disorders Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 16. Global Genetic Testing For Neurological Disorders Market Size Market Share by Application in 2025
Figure 17. Global Genetic Testing For Neurological Disorders Revenue Market Share by Player in 2025
Figure 18. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 19. Americas Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 20. APAC Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 21. Europe Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Genetic Testing For Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 23. Americas Genetic Testing For Neurological Disorders Value Market Share by Country in 2025
Figure 24. United States Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2025
Figure 29. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 30. APAC Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 31. China Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 35. India Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2025
Figure 38. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 39. Europe Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 40. Germany Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 41. France Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Genetic Testing For Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Genetic Testing For Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 54. APAC Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 55. Europe Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 57. United States Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 58. Canada Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 59. Mexico Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 60. Brazil Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 61. China Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 62. Japan Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 63. Korea Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 65. India Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 66. Australia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 67. Germany Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 68. France Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 69. UK Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 70. Italy Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 71. Russia Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 72. Egypt Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 73. South Africa Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 74. Israel Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 75. Turkey Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 76. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Genetic Testing For Neurological Disorders Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Genetic Testing For Neurological Disorders Market Size 2027-2032 ($ millions)
